Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06926881 · ClinicalTrials.gov registry record · NA
OLE Therapy With BE Patients in Home Care Study
A NA study of Bronchiectasis and Pulmonary Exacerbation, sponsored by Delve Health.
- Recruiting
- Registry status
- NA
- Development phase
- 85
- Enrollment target
- 4
- Study locations
NCT06926881 is a NA study of Bronchiectasis and Pulmonary Exacerbation that is actively recruiting participants, run by Delve Health. The registered enrollment target is 85 participants, below the 381-participant average among 13 other Bronchiectasis trials with a reported enrollment target (78% lower). The trial reports 4 study locations across 1 state.
The verdict
NCT06926881, a NA study of Bronchiectasis and Pulmonary Exacerbation, is actively recruiting participants, sponsored by Delve Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
- 4
- Study locations
Study Summary
The study will examine how the performance of Oscillating Lung Expansion (OLE) therapy affects the respiratory health of patients with Bronchiectasis (BE). The patient will use the BiWaze Clear system for their airway clearance therapy, instead of their previously prescribed therapy. BiWaze Clear is an FDA-cleared respiratory therapy for assisting patients in loosening and mobilizing secretions as well as treating and preventing atelectasis by providing lung expansion and high-frequency oscillation therapies, combined with aerosol delivery. The patient will perform airway clearance with BiWaze Clear as prescribed. The system uses a disposable breathing circuit, which is a single patient use, disposable circuit. The treatment duration is 6 months . The BiWaze Clear System is indicated for the mobilization of secretions, lung expansion therapy, the treatment and prevention of pulmonary atelectasis and has the ability to provide supplemental oxygen when used with an oxygen supply.
Conditions Studied
Interventions
- DEVICE BiWaze Clear System
Study Locations (4)
Florida
- Central Florida Pulmonary Group, P.A. - Orlando
- Treasure Coast Medical Research Group, LLC - Port Saint Lucie
- Metropolitan Clinical Research - Tamarac
- University of South Florida -Tampa General Hospital - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2025-05-20 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06926881
The ClinicalTrials.gov registry entry for NCT06926881 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 381-participant average among 13 other Bronchiectasis trials with a reported enrollment target (78% lower). The listed sponsor is Delve Health, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Bronchiectasis appearing as the primary indexed condition, and to 1 intervention - of which BiWaze Clear System is the first listed.
NCT06926881 reports 4 study locations spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06926881 about?
NCT06926881 is a clinical study titled "OLE Therapy With BE Patients in Home Care Study". The study will examine how the performance of Oscillating Lung Expansion (OLE) therapy affects the respiratory health of patients with Bronchiectasis (BE). The patient will use the BiWaze Clear system for their airway clearance therapy, instead of their previously prescribed therapy. BiWaze Clear i...
What is the current status of trial NCT06926881?
This trial is currently recruiting. It is a NA study. The enrollment target is 85 participants. The study started on 2025-05-20. Estimated completion is 2026-08-31.
What conditions does trial NCT06926881 study?
This clinical trial studies the following conditions: Bronchiectasis, Pulmonary Exacerbation.
What interventions are being tested in trial NCT06926881?
The interventions under investigation include: BiWaze Clear System (DEVICE).
Who is sponsoring clinical trial NCT06926881?
This trial is sponsored by Delve Health, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06926881 being conducted?
This trial has 4 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bronchiectasis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease
RECRUITING · NA
-
Acoustic Waveform Respiratory Evaluation
RECRUITING · NA
-
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
COMPLETED · NA
-
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
RECRUITING · Phase 3
-
Evaluation Of The Lung Microbiome In NTM Bronchiectasis
RECRUITING
-
Itraconazole Therapy In Bronchiectasis With Airway Mold
RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.